Human Genome Epidemiology Literature Finder
Records 1 - 5 (of 5 Records) |
Query Trace: Breast Neoplasms and SLCO1A2[original query] |
---|
Polymorphisms of the nuclear receptor pregnane X receptor and organic anion transporter polypeptides 1A2, 1B1, 1B3, and 2B1 are not associated with breast cancer risk. Breast cancer research and treatment 2011 Jan 125 (2): 563-9. Justenhoven Christina, Schaeffeler Elke, Winter Stefan, Baisch Christian, Hamann Ute, Harth Volker, Rabstein Sylvia, Spickenheuer Anne, Pesch Beate, Brüning Thomas, Ko Yon-Dschun, Schwab Matthias, Brauch Hiltr |
High-throughput pharmacogenetics identifies SLCO1A2 polymorphisms as candidates to elucidate the risk of febrile neutropenia in the breast cancer RAPP-01 trial. Breast cancer research and treatment 2015 Sep 153 (2): 383-9. Callens Céline, Debled Marc, Delord Marc, Turbiez-Stalain Isabelle, Veyret Corinne, Bièche Ivan, Brain Etien |
First genome-wide association study on rocuronium dose requirements shows association with SLCO1A2.
![]() British journal of anaesthesia 2021 3 126 (5): 949-957. Ahlström Sirkku, Bergman Paula, Jokela Ritva, Ottensmann Linda, Ahola-Olli Ari, Pirinen Matti, Olkkola Klaus T, Kaunisto Mari A, Kalso Ei |
SLC46A1 Haplotype with Predicted Functional Impact has Prognostic Value in Breast Carcinoma. Molecular diagnosis & therapy 2021 1 25 (1): 99-110. Hlavac Viktor, Vaclavikova Radka, Brynychova Veronika, Dvorak Pavel, Elsnerova Katerina, Kozevnikovova Renata, Raus Karel, Kopeckova Katerina, Mestakova Sona, Vrana David, Gatek Jiri, Soucek Pav |
Impact of organic anion transporting polypeptide, P-glycoprotein, and breast cancer resistance protein transporters on observed tamoxifen and endoxifen concentration and adverse effects. Pharmacogenetics and genomics 2022 11 33 (1): 10-18. Keller Denise N, Medwid Samantha J, Ross Cameron D, Wigle Theodore J, Kim Richard |
- Page last reviewed:Feb 1, 2023
- Page last updated:Jun 02, 2023
- Content source: